Skip to main content

Jones Erin's Form 4 filing

Gritstone bio, Inc. (GRTS) · filed Oct 5, 2021

Accession no.
0001567619-21-017938
Filed
Oct 5, 2021, 4:30 PM ET
Trade date
Oct 1-4, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $21.4K. It was filed 4 days after the trade.

This filing was later replaced by the amendment 0001567619-21-021600 (Dec 3, 2021). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones ErinCIK 0001754278Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2021Common StockMOption exerciseAcquired+1,000$0.345+$34521,000Direct
Oct 1, 2021Common StockSSaleDisposed−1,000$10.68−$10,68020,000Direct
Oct 4, 2021Common StockMOption exerciseAcquired+1,000$0.345+$34521,000Direct
Oct 4, 2021Common StockSSaleDisposed−1,000$10.71−$10,71020,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 1, 2021Common StockMOption exerciseDisposed−1,000$0.00$034,971Direct
Oct 4, 2021Common StockMOption exerciseDisposed−1,000$0.00$033,971Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

Executive Vice President, Global Regulatory Affairs and Quality

Read the full filing on SEC EDGAR (opens in a new tab)